Paving the way to a more effective informed consent process: Recommendations from the Clinical Trials Transformation Initiative.
Ethically sound clinical research requires that prospective study participants provide voluntary informed consent before any study procedures begin. The original intent was to provide the participant with clear, accurate information about study specifics (e.g., risks/benefits) to aid in the decision to participate. Broad consensus among sponsors, research staff, study participants, and advocates indicate that the current process could be improved to enhance participants' understanding of study-related information and meet the needs of individuals. The Clinical Trials Transformation Initiative (CTTI) convened a project to identify problems in the current process and to formulate recommendations for improvement. A literature review, expert interviews, and multi-stakeholder meeting were conducted to identify barriers and develop solutions for a more effective informed consent process. Four key topics were the foundation of the recommendations: 1) defining an effective informed consent process, 2) training research staff, 3) improving the informed consent document, and 4) exploring the use of electronic consent. The ideal informed consent process involves an ongoing, interactive conversation between the participant and knowledgeable, responsive research staff who were trained in best practices. The informed consent process should be supported by a tiered informed consent document that provides critically relevant information to aid in the decision to participate in a study. Adoption of the CTTI informed consent recommendations should lead to a more participant-centric informed consent process. Participant involvement better meets the needs of participants and benefits the clinical trial enterprise by promoting a research culture that encourages informed participation in clinical studies.
Eli Lilly and Company, Indianapolis, IN, USA.
Jennifer
J
Lentz
University of Missouri, Columbia, MO, USA.
Michele
M
Kennett
Patient Advocate.
Jane
J
Perlmutter
Clinical Trials Transformation Initiative, Durham, NC, USA. Electronic address: ctti@mc.duke.edu.
Annemarie
A
Forrest
D035843:Biomedical Research; D002986:Clinical Trials as Topic; D032962:Consent Forms; D032984:Ethics, Research; D017408:Guidelines as Topic; D006801:Humans; D007258:Informed Consent
Clinical research; Decision-making; Health policy; Informed consent; Institutional review board; Research ethics